
Information Technology · Application Software
$191.68
+1.01%
Vol: 16.4M
Monday, June 15, 2026
No material news in the last 48 hours.
Oracle reported record fiscal Q4 and FY2026 results on June 10, with total quarterly revenue up 21% to $19.2B and cloud revenue up 47% to $9.9B, driven by 93% growth in Cloud Infrastructure. Despite the beat, shares fell roughly 13% as investors focused on a massive ~$95B capital-spending plan, plans to raise about $20B in new debt, and physical bottlenecks in data-center deliveries, fanning concerns about cash burn. The company cited a remaining performance obligation of about $638B, signaling strong future revenue. The stock trades near $184 with a P/E around 31. Why it matters: OCI demand is exploding but the AI-infrastructure buildout is capital-intensive. The risk is margin and balance-sheet pressure if monetization lags the spending. Some analysts (e.g., TD Cowen) raised targets.
Oracle has become the first hyperscale cloud provider to deploy Nvidia's new Vera CPU systems at scale, a major AI infrastructure milestone. Wedbush raised its Oracle price target to $275 from $225 on May 13. Oracle received a new buy recommendation on May 19. Q3 FY2026 results showed 20%+ organic revenue and non-GAAP EPS growth, and Oracle raised its FY2027 revenue outlook. AI infrastructure revenue grew 243% with a $553B remaining performance obligations backlog. Oracle elected Cleveland Clinic CEO Dr. Tomislav Mihaljevic to its board effective May 6. The company was named a Leader in the 2026 Gartner Magic Quadrant for Transportation Management. Concerns persist over recent 20,000-30,000 layoffs. Stock at $184.97 with analysts implying ~30.85% upside.
Oracle's remaining performance obligations have grown to $553B, including a five-year $300B cloud contract with OpenAI, framing the stock as a leading AI infrastructure beneficiary. Arete Research upgraded Oracle to Buy citing supply constraints, and shares have rallied on a separate Pentagon AI contract narrative. The board unanimously elected Cleveland Clinic CEO Dr. Tomislav Mihaljevic as a director effective May 6, expanding the board to 13. Oracle launched OCI Enterprise AI in May and made Grok 4.3 available one day after public release. Samsung Electronics adopted Oracle's Java SE Universal Subscription to standardize global semiconductor software development. Oracle was named a Leader in Gartner's 2026 Magic Quadrant for Warehouse Management Systems (11th consecutive year). Key risks remain rising debt and negative free cash flow from the massive data center buildout. Shares traded around $188-198 through mid-May.
On May 13, 2026, Wedbush's Dan Ives raised Oracle's price target to $275 from $225 (Outperform) and Oppenheimer's Brian Schwartz raised to $235 from $210 (Outperform). Oracle announced Samsung Electronics is adopting Oracle Java SE Universal Subscription to standardize global semiconductor software development. Oracle and AWS expanded multicloud networking to deliver private high-performance connectivity between OCI and AWS Interconnect to accelerate AI modernization. Oracle elected Cleveland Clinic CEO Tomislav Mihaljevic to its board effective May 6, expanding to 13 directors, and was named a Leader in two Gartner Magic Quadrants (WMS for 11th year, TMS for 19th time). Bear case: ORCL fell 3.3% to $186.61 on May 18 on profit-taking, and the stock's GuruFocus assessment flags overvaluation despite strong cloud momentum.
No material news in the last 48 hours.
On May 1, Oracle entered an agreement with the U.S. Department of War to deploy advanced AI capabilities on classified networks via 10 dedicated U.S. government cloud regions. On May 8, Oracle launched OCI Enterprise AI with access to Grok 4.3 and NVIDIA Nemotron 3 Nano Omni, alongside SoftBank's adoption of OCI for a Japan sovereign cloud platform. Wedbush raised its target to $275 from $225, Arete upgraded Oracle to Buy from Neutral with a $255 target citing GPU economics, and Oppenheimer raised its target to $235 from $210 (Outperform). Oracle de-risked the AI buildout by raising $30B and securing $29B in customer-prepaid contracts. The board unanimously elected Dr. Tomislav Mihaljevic on May 12. Shares are around $193.71 with a 1-month gain of nearly 22%.
Oracle shares fell 3.62% to close at $186.83 on May 13, 2026, as hotter-than-expected US inflation data and persistent investor unease about the company's aggressive AI capital-expenditure program weighed on the stock — down from a $345 peak in October 2025. FY26 capex is projected near $50B, with free cash flow deeply negative and non-current debt swelling from $85.3B to $124.7B, while interest expense climbed 32% YoY. Despite the pullback, Wedbush Securities on May 12 raised its PT to $275 from $225, reiterating Outperform on growing confidence in Oracle's OpenAI collaboration and broader data-center expansion. Arete's Adam Shepherd separately upgraded to Buy from Neutral with a $255 PT, citing GPU supply constraints helping economics. Oracle has secured $29B in customer-prepaid contracts and reported a record $553B RPO. Risk: the rapid balance-sheet leverage build leaves Oracle exposed if AI demand normalizes before the capex cycle pays back.
Oracle shares dropped 4.7% on May 12 to $186.37 after a hotter-than-expected CPI report, extending a six-session 14% decline; the stock is down nearly 50% from its September peak. Arete's Adam Shepherd upgraded Oracle to Buy from Neutral with a $255 PT, citing tight GPU supply economics. Wedbush launched coverage at Outperform with a $225 PT, arguing the market is underpricing Oracle's AI cloud and misreading the current spending surge. Oracle has raised $30B and secured $29B in customer-prepaid contracts to de-risk its AI build-out free cash flow concerns. Oppenheimer expects strong fiscal Q4 results. Oracle AI World Tour 2026 is in progress; Eightfold AI integrated with Oracle Fusion on May 7, and on May 12 Oracle announced Java SE Universal Subscription enhancements for Samsung. Recent layoffs of 20-30K employees raise some execution concerns. Consensus PT is $260.11 (Buy across 36 analysts).
Oracle shares ended a six-session rally with a 1.14% pullback to $193.71 on May 11, having gained ~14% between May 1 and May 8 versus the S&P 500's 2.33% rise. The rally is tied to AI-focused cloud infrastructure deals and a new Pentagon AI contract. Oracle reportedly raised $30B and secured $29B in customer-prepaid contracts, with record RPO of $553B. Arete upgraded Oracle to Buy on May 7 citing supply constraints; Wedbush initiated coverage at Outperform with a $225 PT. Risk: company is navigating reported layoffs of 20,000-30,000 employees with no severance negotiations, raising execution and culture concerns. Stock has dropped ~50% from its September peak before the recent bounce.
Oracle shares fell roughly 4% on May 7 after reports that OpenAI - a key Oracle cloud customer - missed growth targets and is struggling to secure $18B in financing, while CoreWeave's losses widened, raising concerns about the durability of Oracle's AI cloud revenue ramp. The stock has dropped nearly 50% from its September peak and is down ~14% over six sessions, trading around $192 on May 11 with a $563B market cap. Pushback over Oracle's earlier AI-related mass layoff (estimated 20-30K, originally communicated March 31) intensified in early May as TechCrunch reported Oracle refused to renegotiate severance and forfeited unvested RSUs. On the positive side, Wedbush launched coverage with Outperform and a $225 PT, and Q3 FY26 results beat expectations. Key risk: customer concentration with OpenAI and CoreWeave plus a heavy debt load against AI capex commitments.
Oracle gained significant momentum with multiple analyst upgrades and strategic AI infrastructure investments. Wedbush initiated Oracle with an Outperform rating and $225 price target, highlighting Oracle as a foundational AI cloud provider with a $553 billion backlog and a major OpenAI cloud agreement expected to drive $30 billion in revenue over five years. Arete upgraded to Buy from Neutral with a $255 price target. Oracle, alongside Blackstone and Related Digital, finalized $16 billion in funding for a three-building Michigan data center campus designed to deliver over 1 GW capacity for AI workloads. Barclays maintained a Buy rating with $240 target. Stock rallied from ~$155 to ~$194 (25% gain) in three weeks, reaching $196.24 with a market cap of $564.4 billion and P/E multiple of 34.94. Challenges include execution risks and competition from Amazon and Microsoft.
Oracle secured access to Pentagon's most sensitive classified networks for government-grade AI infrastructure—a coveted achievement. Shares climbed 8.7% on Monday. Company reported Q3 FY2026 revenue of $17.2B (up 22% YoY) with Strong Buy consensus (33 Buys vs. 1 Sell). Revenue guidance raised to $90B for FY2027. Project Jupiter data center buildout with Bloom Energy partnership progressing amid $553B backlog.
Oracle secured a significant milestone by being granted access to the Pentagon's classified networks for deploying AI capabilities, marking Oracle's entry into government-grade AI infrastructure. Shares climbed roughly 8.7% on Monday following the news, with the stock recovering amid broader software sector strength. Oracle is advancing Project Jupiter, a strategic buildout of its own data center capacity for compute-intensive workloads, with deepened partnerships including Bloom Energy providing fuel cell technology for facilities. However, Oracle faces headwinds: the company is implementing significant layoffs (estimated 30,000 roles) to manage finances and encountering challenges securing billions in bank loans for AI data centers due to lender exposure limits. Oracle canceled a server order worth $1.05-1.4 billion and Morgan Stanley cut price targets. The stock remains 47% below its 52-week high of EUR 280.70 from September 2025 and has shed 10%+ since year-start. Analyst price targets range from $155 to $400.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| ORCLORACLE | $191.68 | +1.01% | +3.2% | 17.6x | 1.66 | $554.0B |
| PLTRPALANTIR | $134.61 | -2.04% | -0.3% | 64.8x | 1.51 | $322.9B |
| APPAPPLOVIN | $520.52 | +7.13% | +5.8% | 23.8x | 2.46 | $175.0B |
| CRMSALESFORCE | $164.51 | -6.70% | -8.3% | 10.6x | 1.15 | $134.8B |
| CDNSCADENCE | $394.07 | +9.93% | +14.0% | 42.0x | 1.15 | $108.8B |
| SNPSSYNOPSYS | $453.85 | -9.95% | -8.8% | 26.3x | 1.21 | $87.0B |
Price below 200d MA — bearish structure.